These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17267451)
1. Non-completion of changes to prescribed medications in people with Parkinson's disease. Ng WT; Caslake R; Counsell CE Age Ageing; 2007 May; 36(3):333-6. PubMed ID: 17267451 [No Abstract] [Full Text] [Related]
2. Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital. Magdalinou KN; Martin A; Kessel B Parkinsonism Relat Disord; 2007 Dec; 13(8):539-40. PubMed ID: 17241810 [TBL] [Abstract][Full Text] [Related]
3. Drug adherence in Parkinson's disease. Leopold NA; Polansky M; Hurka MR Mov Disord; 2004 May; 19(5):513-7. PubMed ID: 15133814 [TBL] [Abstract][Full Text] [Related]
4. Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence. Tarrants ML; Denarié MF; Castelli-Haley J; Millard J; Zhang D Am J Geriatr Pharmacother; 2010 Aug; 8(4):374-83. PubMed ID: 20869623 [TBL] [Abstract][Full Text] [Related]
6. Drugs for Parkinson's disease. Treat Guidel Med Lett; 2007 Oct; 5(62):89-94. PubMed ID: 17873854 [No Abstract] [Full Text] [Related]
7. Drugs for Parkinson's Disease. Treat Guidel Med Lett; 2004 Jun; 2(22):41-6. PubMed ID: 15529113 [No Abstract] [Full Text] [Related]
8. Intervening in the neuropsychiatric features of Parkinson's disease. Weintraub D; Stern MB Expert Rev Neurother; 2007 Jun; 7(6):699-710. PubMed ID: 17563252 [TBL] [Abstract][Full Text] [Related]
9. Pill counts, self reports, and electronic monitoring -- which is most informative in the study of therapy adherence in Parkinson's disease? Grosset K; Grosset D Mov Disord; 2007 Nov; 22(15):2294. PubMed ID: 17724748 [No Abstract] [Full Text] [Related]
10. Management of the behavioral aspects of Parkinson's disease. Borek LL; Chou KL; Friedman JH Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253 [TBL] [Abstract][Full Text] [Related]
11. [Revision of the treatment strategy in Parkinson's disease]. Ned Tijdschr Geneeskd; 1986 Jul; 130(28):1291-3. PubMed ID: 3748207 [No Abstract] [Full Text] [Related]
12. [Insufficient medication compliance in Parkinson's disease]. Aerts MB; van der Eijk M; Kramers K; Bloem BR Ned Tijdschr Geneeskd; 2011; 155():A3031. PubMed ID: 21527053 [TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease. Setter SM Neurol Clin; 2008 Aug; 26(3 Suppl):S45-63, vi. PubMed ID: 18774442 [TBL] [Abstract][Full Text] [Related]
14. Adherence to antiparkinson medication in a multicenter European study. Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340 [TBL] [Abstract][Full Text] [Related]
15. My husband's journey with Parkinson's disease. Stone C RN; 2008 Oct; 71(10):27-8. PubMed ID: 18942322 [No Abstract] [Full Text] [Related]
16. Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease. Garcia Ruiz PJ Mov Disord; 2006 May; 21(5):727-8. PubMed ID: 16547919 [No Abstract] [Full Text] [Related]
17. [Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations]. Castaño B; Mateo D; Giménez-Roldán S Neurologia; 2007 Apr; 22(3):133-7. PubMed ID: 17364250 [TBL] [Abstract][Full Text] [Related]
18. Initiation of medications for Parkinson's disease: a qualitative description. Shin JY; Habermann B J Clin Nurs; 2016 Jan; 25(1-2):127-33. PubMed ID: 26420046 [TBL] [Abstract][Full Text] [Related]